Fulvestrant

FDA Approved: * March 4, 2019
Pharm Company: * AMNEAL PHARMS CO
Category: Cancer

Fulvestrant, sold under the brand name Faslodex among others, is a medication used to treat hormone receptor (HR)-positive metastatic breast cancer in postmenopausal women with disease progression as well as HR-positive, HER2-negative advanced breast cancer in combination with palbociclib in women with disease progression after endocrine therapy.[2] It is given by injection into a muscle.[3] Fulvestrant is a selective estrogen receptor degrader (SERD) and was f... [wikipedia]

* May have multiple approval dates, manufacturers, or labelers.
2 Discussions

Dosage List

Fulvestrant 50 mg/ml Intramuscular Injection
NDC: 0143-9022
Labeler:
Hikma Pharmaceuticals USA Inc.
Fulvestrant 50 mg/ml Intramuscular Injection
NDC: 0310-7720
Labeler:
Astrazeneca Pharmaceuticals Lp
Fulvestrant 250 mg/5ml Intramuscular Injection
NDC: 0591-5019
Labeler:
Actavis Pharma, Inc.
Fulvestrant 50 mg/ml Intramuscular Injection
NDC: 0781-3079
Labeler:
Sandoz Inc
Fulvestrant 50 mg/ml Intramuscular Injection
NDC: 0781-3492
Labeler:
Sandoz Inc
Fulvestrant 50 mg/ml Intramuscular Injection
NDC: 0781-3532
Labeler:
Sandoz Inc
Fulvestrant 50 mg/ml Intramuscular Injection
NDC: 0781-9055
Labeler:
Sandoz Inc
Fulvestrant 50 mg/ml Intramuscular Injection, Solution
NDC: 16714-070
Labeler:
Northstar Rx, LLC,
Fulvestrant 50 mg/ml Intramuscular Injection
NDC: 16714-118
Labeler:
Northstar Rxllc
Fulvestrant 250 mg/5ml Intramuscular Injection
NDC: 16729-436
Labeler:
Accord Healthcare Inc.
More Results

Related Brands

Drugs with the same active ingredients

Popular Topics

Fulvestrant and Belviqside

I have stage IV breast cancer. After being unable to control cancer with different endocrine therapy my oncologist put m...

1 REPLY